Next-Generation In Vivo Immune Engineering Platforms: Considerations & Learnings to Optimise Transfer
Time: 9:00 am
day: Workshop A - AM
Details:
Attend this workshop to:
- Understand the differences, advantages and limitations of both ex vivo and in vivo approaches
- Evaluate engineering methods and delivery platforms to ensure specific CAR expression in target tissue
- Evaluate in vivo modalities from lipid nanoparticles to viral vectors to outline options for cost, payload and scalability
- Discuss the possibility for in vivo engineering in innate immune cells as well as applicability to non-oncology indications
